A common microdeletion affecting a hippocampus- and amygdala-specific isoform of tryptophan hydroxylase 2 is not associated with affective disorders

Bipolar Disorders

Volumn 16, Issue 7, 2014, Pages 764-768

  Hammer, Christian ^a   Degenhardt, Franziska ^b   Priebe, Lutz ^b   Stütz, Adrian M ^c   Heilmann, Stefanie ^b   Waszak, Sebastian M ^c   Schlattl, Andreas ^c   Mangold, Elisabeth ^b   Hoffmann, Per ^b,d,e   Nöthen, Markus M ^b,f   Rietschel, Marcella ^g   Rappold, Gudrun ^a   Korbel, Jan ^c   Cichon, Sven ^b,d,e   Niesler, Beate ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^d FORSCHUNGSZENTRUM JÜLICH   (Germany)

^e UNIVERSITY OF BASEL   (Switzerland)

^f GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^g MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

Author keywords

5 hydroxytryptamine (5 HT); Bipolar affective disorder (BPAD); Copy number polymorphism (CNP); Deletion; Major depressive disorder (MDD); Serotonin; Tryptophan hydroxylase 2 (TPH2)

Indexed keywords

CHAPERONE; ENZYME; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE 2; TPH2 PROTEIN, HUMAN; TRYPTOPHAN HYDROXYLASE;

AMYGDALOID NUCLEUS; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; COPY NUMBER VARIATION; EXON; GENE DELETION; GENE LOCUS; GENETIC ASSOCIATION; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; STOP CODON; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; MALE; MOOD DISORDER; PATHOLOGY;

AMYGDALA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HIPPOCAMPUS; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MOOD DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE; TRYPTOPHAN HYDROXYLASE;

EID: 84925970128     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12207     Document Type: Article

References (45)

1. Mehler-Wex C, Renner TJ. [Genetic findings in schizophrenia]. Z Kinder Jugendpsychiatr Psychother 2008; 36: 17-26.
2. Coppen A. The biochemistry of affective disorders. Br J Psychiatry 1967; 113: 1237-1264.
3. Coppen A. Defects in monoamine metabolism and their possible importance in the pathogenesis of depressive syndromes. Psychiatr Neurol Neurochir 1969; 72: 173-180.
4. Anguelova M, Benkelfat C, Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders. Mol Psychiatry 2003; 8: 574-591.
5. Gross C, Hen R. Genetic and environmental factors interact to influence anxiety. Neurotox Res 2004; 6: 493-501.
6. Baumgarten HG, Göthert M. Serotonergic Neurons and 5-HT Receptors in the CNS. Handbook of Experimental Pharmacology, Vol. 129. Berlin: Springer-Verlag, 1997.
7. Hannon J, Hoyer D. Molecular biology of 5-HT receptors. Behav Brain Res 2008; 195: 198-213.
8. Sugden K, Tichopad A, Khan N, Craig IW, D'Souza UM. Genes within the serotonergic system are differentially expressed in human brain. BMC Neurosci 2009; 10: 50.
9. Walther DJ, Peter JU, Bashammakh S et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 2003; 299: 76.
10. Zhang X, Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 2004; 305: 217.
11. McKinney J, Johansson S, Halmoy A et al. A loss-of-function mutation in tryptophan hydroxylase 2 segregating with attention-deficit/hyperactivity disorder. Mol Psychiatry 2008; 13: 365-367.
12. Cichon S, Winge I, Mattheisen M et al. Brain-specific tryptophan hydroxylase 2 (TPH2): a functional Pro206Ser substitution and variation in the 5'-region are associated with bipolar affective disorder. Hum Mol Genet 2008; 17: 87-97.
13. Zhang X, Gainetdinov RR, Beaulieu JM et al. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 2005; 45: 11-16.
14. Hammer C, Cichon S, Muhleisen TW et al. Replication of functional serotonin receptor type 3A and B variants in bipolar affective disorder: a European multicenter study. Transl Psychiatry 2012; 2: e103.
15. Kishi T, Okochi T, Tsunoka T et al. Serotonin 1A receptor gene, schizophrenia and bipolar disorder: an association study and meta-analysis. Psychiatry Res 2011; 185: 20-26.
16. Ohtsuki T, Ishiguro H, Detera-Wadleigh SD et al. Association between serotonin 4 receptor gene polymorphisms and bipolar disorder in Japanese case-control samples and the NIMH Genetics Initiative Bipolar Pedigrees. Mol Psychiatry 2002; 7: 954-961.
17. McAuley EZ, Fullerton JM, Blair IP, Donald JA, Mitchell PB, Schofield PR. Association between the serotonin 2A receptor gene and bipolar affective disorder in an Australian cohort. Psychiatr Genet 2009; 19: 244-252.
18. Yosifova A, Mushiroda T, Stoianov D et al. Case-control association study of 65 candidate genes revealed a possible association of a SNP of HTR5A to be a factor susceptible to bipolar disease in Bulgarian population. J Affect Disord 2009; 117: 87-97.
19. Szczepankiewicz A. Evidence for single nucleotide polymorphisms and their association with bipolar disorder. Neuropsychiatr Dis Treat 2013; 9: 1573-1582.
20. Niesler B, Flohr T, Nothen MM et al. Association between the 5' UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder. Pharmacogenetics 2001; 11: 471-475.
21. Frank B, Niesler B, Nothen MM et al. Investigation of the human serotonin receptor gene HTR3B in bipolar affective and schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet 2004; 131B: 1-5.
22. Huang YY, Oquendo MA, Friedman JM et al. Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism. Neuropsychopharmacology 2003; 28: 163-169.
23. Haenisch B, Linsel K, Bruss M et al. Association of major depression with rare functional variants in norepinephrine transporter and serotonin1A receptor genes. Am J Med Genet B Neuropsychiatr Genet 2009; 150B: 1013-1016.
24. Gu L, Long J, Yan Y et al. HTR2A-1438A/G polymorphism influences the risk of schizophrenia but not bipolar disorder or major depressive disorder: a meta-analysis. J Neurosci Res 2013; 91: 623-633.
25. Richards M, Iijima Y, Kondo H et al. Association study of the vesicular monoamine transporter 1 (VMAT1) gene with schizophrenia in a Japanese population. Behav Brain Funct 2006; 2: 39.
26. Ni J, Lu W, Wu Z, Chen J, Yi Z, Zhang C. T102C polymorphism of serotonin 2A type receptor gene confers susceptibility to (early onset) schizophrenia in Han Chinese: an association study and meta-analysis. Asia Pac Psychiatry 2013; 5: 24-30.
27. Li W, Yang Y, Lin J et al. Association of serotonin transporter gene (SLC6A4) polymorphisms with schizophrenia susceptibility and symptoms in a Chinese-Han population. Prog Neuropsychopharmacol Biol Psychiatry 2013; 44: 290-295.
28. Malhotra D, Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 2012; 148: 1223-1241.
29. Priebe L, Degenhardt FA, Herms S et al. Genome-wide survey implicates the influence of copy number variants (CNVs) in the development of early-onset bipolar disorder. Mol Psychiatry 2012; 17: 421-432.
30. Degenhardt F, Priebe L, Herms S et al. Association between copy number variants in 16p11.2 and major depressive disorder in a German case-control sample. Am J Med Genet B Neuropsychiatr Genet 2012; 159B: 263-273.
31. Maher B. Personal genomes: the case of the missing heritability. Nature 2008; 456: 18-21.
32. Sullivan PF, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 2012; 13: 537-551.
33. Keller MC, Miller G. Resolving the paradox of common, harmful, heritable mental disorders: which evolutionary genetic models work best? Behav Brain Sci 2006; 29: 385-404.
34. The 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 2010; 467: 1061-1073.
35. Cichon S, Muhleisen TW, Degenhardt FA et al. Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet 2011; 88: 372-381.
36. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry 1992; 49: 624-629.
37. Korbel JO, Abyzov A, Mu XJ et al. PEMer: a computational framework with simulation-based error models for inferring genomic structural variants from massive paired-end sequencing data. Genome Biol 2009; 10: R23.
38. Korbel JO, Urban AE, Affourtit JP et al. Paired-end mapping reveals extensive structural variation in the human genome. Science 2007; 318: 420-426.
39. Ota T, Suzuki Y, Nishikawa T et al. Complete sequencing and characterization of 21, 243 full-length human cDNAs. Nat Genet 2004; 36: 40-45.
40. Iafrate AJ, Feuk L, Rivera MN et al. Detection of large-scale variation in the human genome. Nat Genet 2004; 36: 949-951.
41. Frey BN, Andreazza AC, Nery FG et al. The role of hippocampus in the pathophysiology of bipolar disorder. Behav Pharmacol 2007; 18: 419-430.
42. Townsend J, Altshuler LL. Emotion processing and regulation in bipolar disorder: a review. Bipolar Disord 2012; 14: 326-339.
43. Gauderman W, Morrison J. QUANTO 1.1: A Computer Program for Power and Sample Size Calculations for Genetic-epidemiology Studies, 2006. Available from: http://hydra.usc.edu/gxe [accessed September 2012].
44. Bach-Mizrachi H, Underwood MD, Kassir SA et al. Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide. Neuropsychopharmacology 2006; 31: 814-824.
45. De Luca V, Likhodi O, Van Tol HH, Kennedy JL, Wong AH. Tryptophan hydroxylase 2 gene expression and promoter polymorphisms in bipolar disorder and schizophrenia. Psychopharmacology 2005; 183: 378-382.